Clinical and experimental advances related to the detection, magnitude and pathobiology of
subclinical portal hypertension in non-alcoholic fatty liver disease (NAFLD), primarily …

Portal hypertension is defined as high blood pressure in the splanchnic venous system and
is most commonly seen in the setting of long-standing liver disease. The consequences of …

Liver resection causes marked perfusion alterations in the liver remnant both on the organ
scale (vascular anatomy) and on the microscale (sinusoidal blood flow on tissue level) …

Nonalcoholic fatty liver disease (NAFLD) advanced to cirrhosis is often complicated by
clinically significant portal hypertension, which is primarily caused by increased intrahepatic …

Nonalcoholic fatty liver disease (NAFLD) is a substantial and growing problem worldwide
and has become the second most common indication for liver transplantation as it may …

Nonalcoholic fatty liver disease (NAFLD) affects at least 25% of the general adult population
worldwide. Because only a fraction of the patients would develop liver-related complications …

Portal hypertension (PH) is a spectrum of complications of chronic liver disease (CLD) and
cirrhosis, with manifestations including ascites, gastroesophageal varices, splenomegaly …

Background and aims The association between prognosis of variceal bleeding and portal
vein thrombosis (PVT) is unclear. In this multicentre study, we determined the effect of PVT …

The prevalence of nonalcoholic fatty liver disease (NAFLD) in the Middle East is increasing
in parallel to an increase in the prevalence of associated risk factors such as obesity …

BACKGROUND The Baveno VI criteria for predicting esophageal varices, ie., liver stiffness
measurement (LSM)< 20 kPa and platelet (PLT) count> 150× 10 9/L, identify patients who …